1J9O - Header Asymmetric Unit

HEADER CYTOKINE 28-MAY-01 1J9O

TITLE SOLUTION STRUCTURE OF HUMAN LYMPHOTACTIN

COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYMPHOTACTIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET3A

KEYWDS CHEMOKINE, CYTOKINE

EXPDTA SOLUTION NMR

AUTHOR E.S.KULOGLU,D.R.MCCASLIN,M.KITABWALLA,C.D.PAUZA,J.L.MARKLEY, AUTHOR 2 B.F.VOLKMAN

REVDAT 3 24-FEB-09 1J9O 1 VERSN REVDAT 2 01-APR-03 1J9O 1 JRNL REVDAT 1 24-OCT-01 1J9O 0

JRNL AUTH E.S.KULOGLU,D.R.MCCASLIN,M.KITABWALLA,C.D.PAUZA, JRNL AUTH 2 J.L.MARKLEY,B.F.VOLKMAN JRNL TITL MONOMERIC SOLUTION STRUCTURE OF THE PROTOTYPICAL JRNL TITL 2 'C' CHEMOKINE LYMPHOTACTIN. JRNL REF BIOCHEMISTRY V. 40 12486 2001 JRNL REFN ISSN 0006-2960 JRNL PMID 11601972 JRNL DOI 10.1021/BI011106P

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DYANA 1.5 REMARK 3 AUTHORS : GUNTERT REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURES ARE BASED ON A TOTAL REMARK 3 OF 1258 NOE-DERIVED DISTANCE CONSTRAINTS, 60 DIHEDRAL ANGLE REMARK 3 CONSTRAINTS AND 4 DISULFIDE BOND CONSTRAINTS.

REMARK 4 REMARK 4 1J9O COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-MAY-01. REMARK 100 THE RCSB ID CODE IS RCSB013534.

REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 283 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : 200MM NACL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 1.3MM HUMAN LYMPHOTACTIN U- REMARK 210 15N-13C; 20 MM PHOSPHATE REMARK 210 BUFFER, 200MM NACL; 1MM HUMAN REMARK 210 LYMPHOTACTIN U-15N; 20 MM REMARK 210 PHOSPHATE BUFFER, 200MM NACL; REMARK 210 1MM HUMAN LYMPHOTACTIN; 20 MM REMARK 210 PHOSPHATE BUFFER, 200MM NACL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY, 3D_ REMARK 210 15N-SEPARATED_NOESY, 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 750 MHZ, 600 MHZ REMARK 210 SPECTROMETER MODEL : DMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : FELIX, NMRPIPE, XWINNMR, XEASY REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY, TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING TRIPLE- RESONANCE REMARK 210 NMR SPECTROSCOPY.

REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 6 -25.47 89.31 REMARK 500 LYS A 8 179.42 -53.23 REMARK 500 ARG A 9 -62.47 -126.92 REMARK 500 VAL A 12 -78.34 -92.78 REMARK 500 SER A 13 -162.10 -117.84 REMARK 500 THR A 15 -138.04 70.05 REMARK 500 THR A 16 -4.57 82.88 REMARK 500 ARG A 18 87.80 -64.63 REMARK 500 LYS A 25 -77.14 -102.65 REMARK 500 SER A 33 -29.83 -39.59 REMARK 500 ARG A 35 55.44 37.67 REMARK 500 ALA A 88 110.04 -175.97 REMARK 500 REMARK 500 REMARK: NULL

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1J8I RELATED DB: PDB REMARK 900 1J8I IS THE ENSEMBLE WHILE THIS ENTRY IS THE MINIMIZED REMARK 900 AVERAGE STRUCTURE OF THE SAME PROTEIN

DBREF 1J9O A 1 93 UNP P47992 XCL1_HUMAN 22 114

SEQRES 1 A 93 VAL GLY SER GLU VAL SER ASP LYS ARG THR CYS VAL SER SEQRES 2 A 93 LEU THR THR GLN ARG LEU PRO VAL SER ARG ILE LYS THR SEQRES 3 A 93 TYR THR ILE THR GLU GLY SER LEU ARG ALA VAL ILE PHE SEQRES 4 A 93 ILE THR LYS ARG GLY LEU LYS VAL CYS ALA ASP PRO GLN SEQRES 5 A 93 ALA THR TRP VAL ARG ASP VAL VAL ARG SER MET ASP ARG SEQRES 6 A 93 LYS SER ASN THR ARG ASN ASN MET ILE GLN THR LYS PRO SEQRES 7 A 93 THR GLY THR GLN GLN SER THR ASN THR ALA VAL THR LEU SEQRES 8 A 93 THR GLY

HELIX 1 1 VAL A 21 ARG A 23 5 3 HELIX 2 2 THR A 54 LYS A 66 1 13

SHEET 1 A 3 ILE A 24 THR A 30 0 SHEET 2 A 3 ALA A 36 THR A 41 -1 N VAL A 37 O THR A 28 SHEET 3 A 3 LYS A 46 ASP A 50 -1 O VAL A 47 N PHE A 39

SSBOND 1 CYS A 11 CYS A 48 1555 1555 1.72

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000